"Emetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.
| Descriptor ID |
D004639
|
| MeSH Number(s) |
D27.505.696.329 D27.505.696.663.050.225 D27.505.954.427.270 D27.505.954.483.560
|
| Concept/Terms |
Emetics- Emetics
- Emetic Agents
- Agents, Emetic
- Emetic Drugs
- Drugs, Emetic
Emetic Effect- Emetic Effect
- Effect, Emetic
- Emetic Effects
- Effects, Emetic
|
Below are MeSH descriptors whose meaning is more general than "Emetics".
Below are MeSH descriptors whose meaning is more specific than "Emetics".
This graph shows the total number of publications written about "Emetics" by people in this website by year, and whether "Emetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 0 | 4 |
| 2007 | 1 | 4 | 5 |
| 2008 | 1 | 2 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 2 | 5 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 4 | 7 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Emetics" by people in Profiles.
-
A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy. Jpn J Clin Oncol. 2019 Feb 01; 49(2):121-129.
-
Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 01; 48(10):950-952.
-
Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study. Support Care Cancer. 2019 Mar; 27(3):1109-1119.
-
50 Years Ago in The Journal of Pediatrics: Public Knowledge of Ipecac Syrup in the Management of Accidental Poisonings. J Pediatr. 2017 12; 191:56.
-
Effects of oral 3% hydrogen peroxide used as an emetic on the gastroduodenal mucosa of healthy dogs. J Vet Emerg Crit Care (San Antonio). 2017 Mar; 27(2):178-184.
-
Genotypic heterogeneity of emetic toxin producing Bacillus cereus isolates from China. FEMS Microbiol Lett. 2017 01; 364(1).
-
Insights into the central pathways involved in the emetic and behavioural responses to exendin-4 in the ferret. Auton Neurosci. 2017 01; 202:122-135.
-
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy. Support Care Cancer. 2017 01; 25(1):289-294.
-
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents. Support Care Cancer. 2017 01; 25(1):271-275.
-
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy. Support Care Cancer. 2017 01; 25(1):277-288.